Does cognitive dysfunction in bipolar disorder qualify as a diagnostic intermediate phenotype? - A perspective paper

Frontiers in Psychiatry

Volumn 9, Issue OCT, 2018, Pages

  Kessing, Lars Vedel ^a   Miskowiak, Kamilla ^a,b  

^a University of Copenhagen ^*  (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bipolar disorder; Cognition; Cognitive dysfunction; Endophenotype; Intermediate phenotype; Schizophrenia; Unipolar disorder

Indexed keywords

EID: 85055129527     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2018.00490     Document Type: Review

References (71)

1. Tse S, Chan S, Ng KL, Yatham LN. Meta-analysis of predictors of favorable employment outcomes among individuals with bipolar disorder. Bipolar Disord. (2014) 16:217-29. doi: 10.1111/bdi.12148
2. Jensen JH, Knorr U, Vinberg M, Kessing LV, Miskowiak KW. Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: Associations with functional abilities. J Affect Disord. (2016) 205:378-86. doi: 10.1016/j.jad.2016.08.018
3. Jaeger J, Berns S, Loftus S, Gonzalez C, Czobor P. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord. (2007) 9:93-102. doi: 10.1111/j.1399-5618.2007.00427.x
4. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry (1970) 126:983-87.
5. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry (2003) 160:636-45. doi: 10.1176/appi.ajp.160.4.636
6. Kendler KS, Neale MC. Endophenotype: a conceptual analysis. Mol Psychiatry (2010) 15:789-97. doi: 10.1038/mp.2010.8
7. Bourne C, Aydemir O, Balanza-Martinez V, Bora E, Brissos S, Cavanagh JT, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand. (2013) 128(3):149-162. doi: 10.1111/acps.12133
8. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatr Scand Suppl. (2007) 434:17-26. doi: 10.1111/j.1600-0447.2007.01055.x
9. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord. (2009) 113:1-20. doi: 10.1016/j.jad.2008.06.009
10. Mann-Wrobel MC, Carreno JT, Dickinson D. Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord. (2011) 13:334-42. doi: 10.1111/j.1399-5618.2011.00935.x
11. Miskowiak KW, Burdick KE, Martinez-Aran A, Bonnin CM, Bowie CR, Carvalho AF, et al. Assessing and addressing cognitive impairment in bipolar disorder: the International Society for Bipolar Disorders Targeting Cognition Task Force recommendations for clinicians. Bipolar Disord. (2018) 20:184-94. doi: 10.1111/bdi.12595
12. Sole B, Jimenez E, Torrent C, Del Mar Bonnin C, Torres I, Reinares M, et al. Cognitive variability in bipolar II disorder: who is cognitively impaired and who is preserved. Bipolar Disord. (2016) 18:288-99. doi: 10.1111/bdi.12385
13. Bora E. Neurocognitive features in clinical subgroups of bipolar disorder: a meta-analysis. J Affect Disord. (2018) 229:125-34. doi: 10.1016/j.jad.2017.12.057
14. Bortolato B, Miskowiak KW, Kohler CA, Vieta E, Carvalho AF. Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses. Neuropsychiatr Dis Treat. (2015) 11:3111-25. doi: 10.2147/NDT.S76700
15. Porter RJ, Robinson LJ, Malhi GS, Gallagher P. The neurocognitive profile of mood disorders - a review of the evidence and methodological issues. Bipolar Disord. (2015) 17(Suppl 2):21-40. doi: 10.1111/bdi.12342
16. Szmulewicz AG, Valerio MP, Smith JM, Samame C, Martino DJ, Strejilevich SA. Neuropsychological profiles of major depressive disorder and bipolar disorder during euthymia. a systematic literature review of comparative studies. Psychiatry Res. (2017) 248:127-33. doi: 10.1016/j.psychres.2016.12.031
17. Van Rheenen TE, Lewandowski KE, Tan EJ, Ospina LH, Ongur D, Neill E, et al. Characterizing cognitive heterogeneity on the schizophrenia-bipolar disorder spectrum. Psychol Med. (2017) 47:1848-64. doi: 10.1017/S0033291717000307
18. Kuswanto C, Chin R, Sum MY, Sengupta S, Fagiolini A, McIntyre RS, et al. Shared and divergent neurocognitive impairments in adult patients with schizophrenia and bipolar disorder: whither the evidence? Neurosci Biobehav Rev. (2016) 61:66-89. doi: 10.1016/j.neubiorev.2015.12.002
19. Hasselbalch BJ, Knorr U, Kessing LV. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect. Disord. (2011) 134:20-31. doi: 10.1016/j.jad.2010.11.011
20. Jaeger J, Berns S, Uzelac S, Davis-Conway S. Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res. (2006) 145:39-48. doi: 10.1016/j.psychres.2005.11.011
21. Strakowski SM, Adler CM, Holland SK, Mills N, DelBello MP. A preliminary FMRI study of sustained attention in euthymic, unmedicated bipolar disorder. Neuropsychopharmacology (2004) 29:1734-40. doi: 10.1038/sj.npp.1300492
22. Kerr N, Dunbar RI, Bentall RP. Theory of mind deficits in bipolar affective disorder. J Affect. Disord. (2003) 73:253-9. doi: 10.1016/S0165-0327(02)00008-3
23. Wessa M, Linke J. Emotional processing in bipolar disorder: behavioural and neuroimaging findings. Int. Rev Psychiatry (2009) 21:357-67. doi: 10.1080/09540260902962156
24. Phillips ML, Swartz HA. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am J Psychiatry (2014) 171:829-43. doi: 10.1176/appi.ajp.2014
25. Miskowiak KW, Carvalho AF. 'Hot' cognition in major depressive disorder: a systematic review. CNS Neurol Disord Drug Targets (2014) 13:1787-803.
26. Miskowiak K, Glerup L, Vestbo C, Harmer CJ, Reinecke A, Macoveanu J, et al. Different neural and cognitive response to emotional faces in healthy monozygotic twins at risk of depression. Psychol Med. (2015) 45:1447-58. doi: 10.1017/S0033291714002542
27. Anticevic A, Schleifer C, Youngsun TC. Emotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanisms. Dialogues Clin Neurosci. (2015) 17:421-34.
28. de Brito Ferreira Fernandes F, Gigante AD, Berutti M, Amaral JA, de Almeida KM, de Almeida Rocca CC, et al. Facial emotion recognition in euthymic patients with bipolar disorder and their unaffected first-degree relatives. Compr Psychiatry (2016) 68:18-23. doi: 10.1016/j.comppsych.2016.03.001
29. Sheffield JM, Kandala S, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA, et al. Transdiagnostic associations between functional brain network integrity and cognition. JAMA Psychiatry (2017) 74:605-13. doi: 10.1001/jamapsychiatry.2017.0669
30. Miskowiak KW, Carvalho AF. 'Hot' cognition in major depressive disorder: a systematic review. CNS Neurol Disord Drug Targets (2014) 13:1787-803.
31. Townsend JD, Torrisi SJ, Lieberman MD, Sugar CA, Bookheimer SY, Altshuler LL. Frontal-amygdala connectivity alterations during emotion downregulation in bipolar I disorder. Biol Psychiatry (2013) 73:127-35. doi: 10.1016/j.biopsych.2012.06.030
32. Cusi AM, Nazarov A, Holshausen K, Macqueen GM, McKinnon MC. Systematic review of the neural basis of social cognition in patients with mood disorders. J Psychiatry Neurosci. (2012) 37:154-69. doi: 10.1503/jpn.100179
33. Misiak B, Stanczykiewicz B, Kotowicz K, Rybakowski JK, Samochowiec J, Frydecka D. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review. Schizophr Res. (2018) 192:16-29. doi: 10.1016/j.schres.2017.04.015
34. Rosenblat JD, Brietzke E, Mansur RB, Maruschak NA, Lee Y, McIntyre RS. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: evidence, pathophysiology and treatment implications. J Affect Disord. (2015) 188:149-59. doi: 10.1016/j.jad.2015.08.058
35. Hope S, Hoseth E, Dieset I, Morch RH, Aas M, Aukrust P, et al. Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls. Schizophr Res. (2015) 165:188-94. doi: 10.1016/j.schres.2015.04.004
36. Bora E. A comparative meta-analysis of neurocognition in first-degree relatives of patients with schizophrenia and bipolar disorder. Eur Psychiatry (2017) 45:121-8. doi: 10.1016/j.eurpsy.2017.06.003
37. Miskowiak KW, Kjaerstad HL, Meluken I, Petersen JZ, Maciel BR, Kohler CA, et al. The search for neuroimaging and cognitive endophenotypes: a critical systematic review of studies involving unaffected first-degree relatives of individuals with bipolar disorder. Neurosci Biobehav Rev. (2017) 73:1-22. doi: 10.1016/j.neubiorev.2016.12.011
38. Kaersgaard S, Meluken I, Kessing LV, Vinberg M, Miskowiak KW. Increased sensitivity to positive social stimuli in monozygotic twins at risk of bipolar vs. unipolar disorder. J Affect Disord. (2018) 232:212-18. doi: 10.1016/j.jad.2018.02.055
39. Kurnianingsih YA, Kuswanto CN, McIntyre RS, Qiu A, Ho BC, Sim K. Neurocognitive-genetic and neuroimaging-genetic research paradigms in schizophrenia and bipolar disorder. J Neural Transm. (2011) 118:1621-39. doi: 10.1007/s00702-011-0672-z
40. Burdick KE, Funke B, Goldberg JF, Bates JA, Jaeger J, Kucherlapati R, et al. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance. Bipolar Disord. (2007) 9:370-6. doi: 10.1111/j.1399-5618.2007.00384.x
41. Tramontina JF, Yates D, Magalhaes PV, Trentini C, Sant'anna MK, Fries GR, et al. Brain-derived neurotrophic factor gene val66met polymorphism and executive functioning in patients with bipolar disorder. Rev Bras Psiquiatr. (2009) 31:136-40. doi: 10.1590/S1516-44462009000200010
42. Miskowiak KW, Kjaerstad HL, Stottrup MM, Svendsen AM, Demant KM, Hoeffding LK, et al. The catechol-O-methyltransferase (COMT) Val158Met genotype modulates working memory-related dorsolateral prefrontal response and performance in bipolar disorder. Bipolar Disord. (2017) 19:214-24. doi: 10.1111/bdi.12497
43. Ryan KA, Assari S, Pester BD, Hinrichs K, Angers K, Baker A, et al. Similar trajectory of executive functioning performance over 5 years among individuals with bipolar disorder and unaffected controls using latent growth modeling. J Affect Disord. (2016) 199:87-94. doi: 10.1016/j.jad.2016.04.016
44. Rosa AR, Magalhaes PV, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, et al. Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry (2014) 75:e450-6. doi: 10.4088/JCP.13m08625
45. Mora E, Portella MJ, Forcada I, Vieta E, Mur M. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol Med. (2013) 43:1187-96. doi: 10.1017/S0033291712001948
46. Bora E, Ozerdem A. Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia. Psychol Med. (2017) 47:2753-66. doi: 10.1017/S0033291717001490
47. Ryan KA, Assari S, Angers K, Marshall DF, Hinrichs K, Easter R, et al. Equivalent linear change in cognition between individuals with bipolar disorder and healthy controls over 5 years. Bipolar Disord. (2017) 19:689-97. doi: 10.1111/bdi.12532
48. Samame C, Martino DJ, Strejilevich SA. Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study. J Affect Disord. (2014) 164:130-8. doi: 10.1016/j.jad.2014.04.028
49. Kessing LV, Dam H, Joergensen OS, Bolwig TG. Cognitive impairment in affective disorders. Relation to illness characteristics. Nord J Psychiatry (1996) 50:305-16.
50. Kessing LV. Cognitive impairment in the euthymic phase of affective disorder. Psychol. Med. (1998) 28:1027-38.
51. Hasselbalch BJ, Knorr U, Hasselbalch SG, Gade A, Kessing LV. The cumulative load of depressive illness is associated with cognitive function in the remitted state of unipolar depressive disorder. Eur Psychiatry (2013) 28:349-55. doi: 10.1016/j.eurpsy.2012.03.004
52. Beats BC, Sahakian BJ, Levy R. Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed. Psychol Med. (1996) 26:591-603. doi: 10.1017/S0033291700035662
53. Paelecke-Habermann Y, Pohl J, Leplow B. Attention and executive functions in remitted major depression patients. J Affect Disord. (2005) 89:125-35. doi: 10.1016/j.jad.2005.09.006
54. Bhardwaj A, Wilkinson P, Srivastava C, Sharma M. Cognitive deficits in euthymic patients with recurrent depression. J Nerv Ment Dis. (2010) 198:513-5. doi: 10.1097/NMD.0b013e3181e4c5ba
55. Kessing LV, Andersen PK. Evidence for clinical progression of unipolar and bipolar disorders. Acta Psychiatr Scand. (2017) 135:51-64. doi: 10.1111/acps.12667
56. da SJ, Goncalves-Pereira M, Xavier M, Mukaetova-Ladinska EB. Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry (2013) 202:177-86. doi: 10.1192/bjp.bp.111.101931
57. Kessing LV, Olsen EW, Mortensen PB, Andersen PK. Dementia in affective disorder: a case-register study. Acta Psychiatr Scand. (1999) 100:176-85.
58. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord. (2003) 73:261-9. doi: 10.1016/S0165-0327(02)00004-6
59. Kessing LV. Depression and the risk for dementia. Curr Opin Psychiatry (2012) 25:457-61. doi: 10.1097/YCO.0b013e328356c368
60. Chen MH, Li CT, Tsai CF, Lin WC, Chang WH, Chen TJ, et al. Risk of subsequent dementia among patients with bipolar disorder or major depression: a nationwide longitudinal study in Taiwan. J Am Med Dir Assoc. (2015) 16:504-8. doi: 10.1016/j.jamda.2015.01.084
61. Wu KY, Chang CM, Liang HY, Wu CS, Chia-Hsuan WE, Chen CH, et al. Increased risk of developing dementia in patients with bipolar disorder: a nested matched case-control study. Bipolar Disord. (2013) 15:787-94. doi: 10.1111/bdi.12116
62. Miskowiak KW, Carvalho AF, Vieta E, Kessing LV. Cognitive enhancement treatments for bipolar disorder: a systematic review and methodological recommendations. Eur Neuropsychopharmacol. (2016) 26:1541-61. doi: 10.1016/j.euroneuro.2016.08.011
63. Alda M, McKinnon M, Blagdon R, Garnham J, MacLellan S, O'Donovan C, et al. Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. Br J Psychiatry (2017) 210:54-60. doi: 10.1192/bjp.bp.115.173930
64. Miskowiak KW, Ott CV, Petersen JZ, Kessing LV. Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field. Eur Neuropsychopharmacol. (2016) 26:1845-67. doi: 10.1016/j.euroneuro.2016.09.641
65. Harvey PD, Bowie CR. Cognitive enhancement in schizophrenia: pharmacological and cognitive remediation approaches. Psychiatr Clin North Am. (2012) 35:683-98. doi: 10.1016/j.psc.2012.06.008
66. Harvey PD, Sand M. Pharmacological augmentation of psychosocial and remediation training efforts in schizophrenia. Front Psychiatry (2017) 8:177. doi: 10.3389/fpsyt.2017.00177
67. Keefe RS, Davis VG, Spagnola NB, Hilt D, Dgetluck N, Ruse S, et al. Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. Eur Neuropsychopharmacol. (2015) 25:176-84. doi: 10.1016/j.euroneuro.2014.06.009
68. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry (2011) 168:472-85. doi: 10.1176/appi.ajp.2010.10060855
69. Revell ER, Neill JC, Harte M, Khan Z, Drake RJ. A systematic review and meta-analysis of cognitive remediation in early schizophrenia. Schizophr Res. (2015) 168:213-22. doi: 10.1016/j.schres.2015.08.017
70. Lewandowski KE, Sperry SH, Cohen BM, Norris LA, Fitzmaurice GM, Ongur D, et al. Treatment to Enhance Cognition in Bipolar Disorder (TREC-BD): efficacy of a randomized controlled trial of cognitive remediation versus active control. J Clin Psychiatry (2017) 78:e1242-9. doi: 10.4088/JCP.17m11476
71. Malhi GS, Byrow Y, Fritz K, Das P, Baune BT, Porter RJ, et al. Mood disorders: neurocognitive models. Bipolar Disord. (2015) 17 (Suppl. 2):3-20. doi: 10.1111/bdi.12353